Denali Therapeutics Inc.
USD23.68
+0.78 (+3.38%)
CEO
Ryan J. Watts
IPO Date
2017-12-08
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$22.68
Prev. Close
$22.90
Day Low
$22.68
Day High
$23.81
52W Low
$12.58
52W High
$27.30
Market Cap
$3.76B
Volume
0.57M
| 19,226 |
| $19.66 |
| 5 Jun 2026 | Klein Peter S | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Klein Peter S | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Krognes Steve E. | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Krognes Steve E. | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Schenkein David P | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Schenkein David P | director | A-Award | Acquired | 19,226 | $19.66 |
| 5 Jun 2026 | Thornberry Nancy | director | A-Award | Acquired | 6,408 | $0.00 |
| 5 Jun 2026 | Thornberry Nancy | director | A-Award | Acquired | 19,226 | $19.66 |